Sponsored Content for Reliis

Patrys makes bold clinical-stage move with acquisition of WA private company Reliis, adding high-value delirium asset to ignite next phase of growth

Australia's research excellence is renowned, consistently ranking among the top in global innovation metrics (7th out of 36 to be exact).

Emerging biotech company Reliis Limited and pharmaceutical manufacturer NovaCina showcase collaboration in the growing WA innovation sector